Eslováquia -
eslovaco -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
panadol migréna
haleon czech republic s.r.o., Česká republika - kyselina acetylsalicylová, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica
União Europeia -
eslovaco -
EMA (European Medicines Agency)
aimovig
novartis europharm limited - erenumab - poruchy migrény - analgetiká - aimovig je indikovaný na profylaxiu migrény u dospelých, ktorí majú aspoň 4 migréna dní za mesiac pri začatí liečby s aimovig.
União Europeia -
eslovaco -
EMA (European Medicines Agency)
emgality
eli lilly nederland b.v. - galcanezumab - poruchy migrény - analgesics, galcanezumab - emgality je indikovaný na profylaxiu migrény u dospelých, ktorí majú aspoň 4 migréna dní za mesiac.
União Europeia -
eslovaco -
EMA (European Medicines Agency)
vydura
pfizer europe ma eeig - rimegepant - poruchy migrény - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
União Europeia -
eslovaco -
EMA (European Medicines Agency)
rayvow
eli lilly nederland b.v. - lasmiditan succinate - poruchy migrény - analgetiká - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.
União Europeia -
eslovaco -
EMA (European Medicines Agency)
aquipta
abbvie deutschland gmbh & co. kg - atogepant - poruchy migrény - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
União Europeia -
eslovaco -
EMA (European Medicines Agency)
ajovy
teva gmbh - fremanezumab - poruchy migrény - calcitonin gene-related peptide (cgrp) antagonists - ajovy je indikovaný na profylaxiu migrény u dospelých, ktorí majú aspoň 4 migréna dní za mesiac.
União Europeia -
eslovaco -
EMA (European Medicines Agency)
vyepti
h. lundbeck a/s - eptinezumab - poruchy migrény - analgetiká - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.